Latest collections open to submissions
NEW: Cancer control in low- and middle-income countries
Guest Edited by Lisa A. Newman, Cristina Stefan and Shenglan Tang
Advances in personalized radiotherapy
Guest Edited by Venkata SK. Manem and Farzad Taghizadeh-Hesary
Cancer metabolism
Guest edited by Elavarasan Subramani and Marija Trajkovic-Arsic
Editors' Picks
Trending BMC Cancer Articles
Click here to view which Articles have been shared most in the last month!
Articles
-
-
AQP8 promotes glioma proliferation and growth, possibly through the ROS/PTEN/AKT signaling pathway
-
Ninety-degree angled collimator: a dosimetric study related to dynamic intensity-modulated radiotherapy in patients with endometrial carcinoma
-
MMR gene patterns evaluation provides novel insights for personalized immunotherapy compared to neoadjuvant chemotherapy in lung adenocarcinama
-
Interaction of lncRNAs with mTOR in colorectal cancer: a systematic review
-
M1 and M2 macrophages derived from THP-1 cells differentially modulate the response of cancer cells to etoposide
-
An electronic application for rapidly calculating Charlson comorbidity score
-
Does colon cancer ever metastasize to bone first? a temporal analysis of colorectal cancer progression
-
Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression
-
Atypical glandular cells in conventional cervical smears: Incidence and follow-up
Targeted Therapies for Cancer
Guest edited by Prof. Min Li and Dr. Yanis Boumber
Open for submissions
Microbiome and Cancer
Guest edited by Christopher Staley, Jacques Ravel, Sean Devlin
Open for submissions
Cross journal collection: Advances in CAR-T immunotherapy
Guest edited by Profs Marko Radic, Djordje Atanackovic and Tim Luetkens
Collection published: 30 June 2020
Cross journal collection: Precision Oncology
Collection published: 28 August 2019
Browse all BMC Cancer collection contributions
MULISARC trial: molecular profiling of advanced soft-tissue sarcomas
THUNDER 2: THeragnostic Utilities for Neoplastic DisEases of the Rectum by MRI guided radiotherapy
Learn more about study protocols at BMC Cancer here
Aims and Scope
BMC Cancer is an open access, peer-reviewed journal that considers articles on all aspects of cancer research, including the pathophysiology, prevention, diagnosis and treatment of cancers. The journal welcomes submissions in broad areas of cancer research including molecular and cellular biology, genetics, epidemiology, and clinical trials. Learn more about our scope here.
Become an Editorial Board Member
We are recruiting new Editorial Board Members.
Read MoreBMC Cancer is celebrating its 20th anniversary!
Since launching in 2001, we've become established as the largest open access oncology journal in our field. We're proud of our history of making cancer research and methods available to all. We have been looking back at our achievements and highlighted some of the most influential research published in the journal over the past two decades.
BMC Series Blog
Latest Tweets
View Twitter timeline
Your browser needs to have JavaScript enabled to view this timeline
Annual Journal Metrics
-
Citation Impact
4.638 - 2-year Impact Factor (2021)
4.672 - 5-year Impact Factor (2021)
1.308 - SNIP (Source Normalized Impact per Paper)
1.134 - SJR SCImago Journal Rank (SJR)Speed
39 days to first decision for all manuscripts (Median)
56 days to first decision for reviewed manuscripts only (Median)Usage
7,665,706 Downloads (2022)
4,517 Altmetric mentions (2021)
Peer-review Terminology
-
The following summary describes the peer review process for this journal:
Identity transparency: Single anonymized
Reviewer interacts with: Editor
Review information published: Review reports. Reviewer Identities reviewer opt in. Author/reviewer communication